MedTrace Logo

Polish Registry of Common Carotid Artery Access for TAVI

NCT03361007 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2020-10-22

No results posted yet for this study

Summary

Transcatheter aortic valve implantation (TAVI) is valuable treatment option for patients, who are at the high risk of surgical aortic valve replacement (AVR). Majority of procedures are performed through femoral arteries, however in some this access cannot be applied. Common carotid artery is one of the alternative routes of delivering the device in those patients. Established registry aims at collecting the data prospectively to assess outcomes of TAVI through common carotid artery.

Conditions

  • Aortic Valve Stenosis
  • Ventricular Outflow Obstruction, Left

Interventions

DEVICE

Transcatheter Aortic Valve Implantation (TAVI)

Patients who were disqualified from surgical cortical valve replacement by decision of the Heart Team.

Sponsors & Collaborators

  • Medical University of Warsaw

    lead OTHER

Principal Investigators

  • Zenon Huczek, MD, PhD · Medical University of Warsaw

  • Radosław Wilimski, MD · Medical University of Warsaw

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2023-12-31
Completion
2024-05-30
FDA Device
Yes

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03361007 on ClinicalTrials.gov